BPL-003 shown to be well-tolerated, with consistent dose delivery, highly reproducible pharmacokinetic profile and reliable induction of profound psychedelic experiences when dosed up to 12 mg in healthy participants BPL-003 is Beckley Psytech’s patent-protected benzoate formulation of 5-MeO-DMT and is administered intranasally via an FDA-approved delivery device MHRA-approved Phase IIa studies of BPL-003 in Treatment … [Read more…]

Global study of 200 cities and 2,000 citizens shows how urban leaders are adjusting their priorities and adapting to changing citizen expectations. NEW YORK–(BUSINESS WIRE)–#buildingafuturereadycity–Social, economic, and environmental disruptions, heightened by the COVID-19 pandemic, are radically altering the expectations and behaviors of citizens, requiring urban leaders around the world to develop action plans to become … [Read more…]

MINNEAPOLIS–(BUSINESS WIRE)–FOXO Technologies Inc. (NYSE_AM: FOXO), a technology platform company whose products and services seek to address long-standing, core problems within the life insurance industry through epigenetic longevity science, today announced that as of November 9, 2022, Erin Sharoni resigned as Chief Product Officer of the company. The Board thanks Erin for her leadership on … [Read more…]

Controlling shareholder provides loan facility TORONTO–(BUSINESS WIRE)–Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological and psychiatric disorders by scientifically harnessing the medicinal power of psychedelic molecules, is pleased to announce that … [Read more…]

IRVINE, Calif.–(BUSINESS WIRE)–#2021MediaReport—Merit Awards, an independent awards program that recognizes global industries and the market they serve, today announced the winners of the Merit Awards for Healthcare. The Merit Awards for Healthcare were judged based on submissions that addressed various healthcare needs ranging from services to tech innovations. “The importance of healthcare has emerged more … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation thanked today the government of the United Kingdom for pledging 1 billion pounds over the next three years for the Seventh Replenishment round of the Global Fund to Fight AIDS, Tuberculosis and Malaria. “We thank the UK government and Prime Minister Sunak for continuing to support the Global Fund despite … [Read more…]

MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the “Company”), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light (“UVC”) for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly and automatically, announced its financial results for the third quarter 2022. Recent Business … [Read more…]

CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) reports financial results for the three and nine months ended September 30, 2022 and provides a business update. On September 9, 2022, Ra Medical entered into an Agreement and Plan of Merger (the “Definitive Merger Agreement”) with privately held Catheter Precision … [Read more…]

Conference Call to be held Tuesday, November 15, 2022 at 5:00 pm (EST) DUBLIN, Ohio–(BUSINESS WIRE)–The seventh bullet under Third Quarter 2022 Highlights and Subsequent Events should read: Received an additional $1.0 million under a bridge loan from the Company’s Vice Chair of the Board of Directors, John K. Scott, Jr. (Instead of: Received an additional $1.5 … [Read more…]

TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, today reported unaudited financial results for its second quarter ended September 30, 2022, and recent business highlights. “We have continued to make progress as planned, advancing our clinical pipeline of modified psychedelic-based molecules while also strengthening … [Read more…]